Clinicopathological relevance of BRAF mutations in human cancer
References (144)
- et al.
Targeting the RAF-MEK-ERK pathway in cancer therapy
Cancer Lett
(2009) - et al.
Ras signaling and therapies
Adv Cancer Res
(2009) - et al.
Raf proteins and cancer: B-Raf is identified as a mutational target
Biochim Biophys Acta
(2003) - et al.
Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma
J Invest Dermatol
(2006) - et al.
Incidence of BRAF p. Val600Glu and p. Val600Lys mutations in a consecutive series of 183 metastatic melanoma patients from a high incidence region
Pathology
(2012) Molecular analysis of thyroid tumors
Mod Pathol
(2011)- et al.
Correlation between BRAF mutation and the clinicopathological parameters in papillary thyroid carcinoma with particular reference to follicular variant
Hum Pathol
(2011) - et al.
BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype-phenotype correlation
Mod Pathol
(2013) Prognostic utility of BRAF mutation in papillary thyroid cancer
Mol Cell Endocrinol
(2010)- et al.
KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants
Gynecol Oncol
(2006)
Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary
Gynecol Oncol
(2010)
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—shifting the paradigm
Hum Pathol
(2011)
Genetic and epigenetic changes in colon cancer
Exp Mol Pathol
(2008)
The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients
Ann Oncol
(2010)
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
Lancet Oncol
(2010)
Paediatric brain tumours treated at a single, tertiary paediatric neurosurgical referral centre from 1999 to 2010 in Australia
J Clin Neurosci
(2012)
Uncommon V599E BRAF mutations in Japanese patients with lung cancer
J Surg Res
(2006)
New driver mutations in non-small-cell lung cancer
Lancet Oncol
(2011)
The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions
Growth Factors
(2006)
Mutations of the BRAF gene in human cancer
Nature
(2002)
Antitumor efficacy of the novel RAF inhibitor GDC-0879 is predicted by BRAFV600E mutational status and sustained extracellular signal-regulated kinase/mitogen- activated protein kinase pathway suppression
Cancer Res
(2009)
Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis
Br J Dermatol
(2011)
BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma
J Clin Oncol
(2012)
High frequency of BRAF mutations in nevi
Nat Genet
(2003)
Prognostic and clinicopatho- logic associations of oncogenic BRAF in metastatic melanoma
J Clin Oncol
(2011)
MC1R germline variants confer risk for BRAF-mutant melanoma
Science
(2006)
Genetic and morphologic features for melanoma classification
Pigment Cell Melanoma Res
(2010)
Improving melanoma classification by integrating genetic and morphologic features
PLoS Med
(2008)
BRAF mutations in advanced cancers: clinical characteristics and outcomes
PloS One
(2011)
NRAS mutation status is an independent prognostic factor in metastatic melanoma
Cancer
(2012)
NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing
Melanoma Res
(2006)
Papillary carcinoma of thyroid: A 30-yr clinicopathological review of the histological variants
Endocr Pathol
(2005)
BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas
J Clin Endocrinol Metab
(2003)
Mutational analysis of BRAF in fine needle aspiration biopsies of the thyroid: a potential application for the preoperative assessment of thyroid nodules
Clin Cancer Res
(2004)
Low frequency ofBRAFT1796A mutations in childhood thyroid carcinomas
J Clin Endocrinol Metab
(2004)
BRAF mutations are uncommon in papillary thyroid cancer of young patients
Thyroid
(2005)
Papillary thyroid carcinomas with and without BRAF? V600E mutations are morphologically distinct
Histopathology
(2012)
Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers
J Clin Endocrinol Metab
(2003)
Mutations of the BRAF gene in papillary thyroid carcinoma in a Korean population
Yonsei Med J
(2004)
The oncogene BRAF V600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I- targeting to the membrane
Endocr Relat Cancer
(2006)
BRAF in primary and recurrent papillary thyroid cancers: the relationship with 131I and 2-[18F] fluoro-2- deoxy-d-glucose uptake ability
Eur J Endocrinol
(2010)
The association of the BRAFV600E mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer
Cancer
(2011)
Follicular variant of papillary thyroid carcinoma: a diagnostic challenge for clinicians and pathologists
Postgrad Med J
(2008)
Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma
Am J Surg Pathol
(2004)
Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAF(T1799A) mutation on fine-needle aspiration biopsy specimens: a prospective study of 814 thyroid FNAB patients
Ann Surg
(2012)
Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma
J Clin Endocrinol Metab
(2004)
BRAF in papillary thyroid carcinoma of ovary (struma ovarii)
Am J SurgPathol
(2007)
BRAF T1799A mutation occurring in a case of malignant struma ovarii
Int J Surg Pathol
(2007)
Expression of benign and malignant thyroid tissue in ovarian teratomas and the importance of multimodal management as illustrated by a BRAF-positive follicular variant of papillary thyroid cancer
Thyroid
(2010)
Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment
Radiographics
(2011)
Cited by (0)
Copyright © 2013 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.